IL22 and breast cancer: To assess the impact of exogenous IL-22 on tumor growth, we applied three breast cancer models by transplanting 4T1 cells to wild type BALB/c mice and transplanting MCF7 cells and MDA-MB-231 cells to BALB/c Nude mice.